nodes	percent_of_prediction	percent_of_DWPC	metapath
Tocainide—Lidocaine—EGFR—bile duct cancer	0.0521	1	CrCbGaD
Tocainide—SCN11A—Developmental Biology—SMAD4—bile duct cancer	0.00507	0.00535	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—MET—bile duct cancer	0.00498	0.00525	CbGpPWpGaD
Tocainide—SCN2A—L1CAM interactions—EGFR—bile duct cancer	0.00496	0.00523	CbGpPWpGaD
Tocainide—SCN4A—L1CAM interactions—EGFR—bile duct cancer	0.00496	0.00523	CbGpPWpGaD
Tocainide—SCN10A—L1CAM interactions—EGFR—bile duct cancer	0.00478	0.00505	CbGpPWpGaD
Tocainide—SCN1A—L1CAM interactions—EGFR—bile duct cancer	0.00478	0.00505	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—SMAD4—bile duct cancer	0.00464	0.00489	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—MMP2—bile duct cancer	0.00454	0.00479	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—ERBB2—bile duct cancer	0.00446	0.00471	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—MET—bile duct cancer	0.00436	0.0046	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—MMP2—bile duct cancer	0.00415	0.00438	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—MET—bile duct cancer	0.00403	0.00425	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—ERBB2—bile duct cancer	0.00398	0.0042	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—MET—bile duct cancer	0.00388	0.0041	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—MET—bile duct cancer	0.00385	0.00406	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—MMP9—bile duct cancer	0.00383	0.00404	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—SMAD4—bile duct cancer	0.00375	0.00396	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00373	0.00393	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—MET—bile duct cancer	0.0037	0.0039	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—MET—bile duct cancer	0.0037	0.0039	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—HGF—bile duct cancer	0.00367	0.00387	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—ERBB2—bile duct cancer	0.00364	0.00384	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—MMP2—bile duct cancer	0.00364	0.00384	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—SMAD4—bile duct cancer	0.00359	0.00379	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—MET—bile duct cancer	0.00357	0.00376	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—MET—bile duct cancer	0.00357	0.00376	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—MET—bile duct cancer	0.00355	0.00375	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—HGF—bile duct cancer	0.0035	0.00369	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—SMAD4—bile duct cancer	0.00345	0.00364	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—SMAD4—bile duct cancer	0.00345	0.00364	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—MMP9—bile duct cancer	0.00341	0.0036	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—NRAS—bile duct cancer	0.0034	0.00358	CbGpPWpGaD
Tocainide—SCN5A—L1CAM interactions—EGFR—bile duct cancer	0.00336	0.00355	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—MMP2—bile duct cancer	0.00336	0.00354	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—SMAD4—bile duct cancer	0.00333	0.00351	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—SMAD4—bile duct cancer	0.00333	0.00351	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—MMP2—bile duct cancer	0.00324	0.00342	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—MMP2—bile duct cancer	0.00321	0.00339	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—ERBB2—bile duct cancer	0.00319	0.00336	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—MMP9—bile duct cancer	0.00312	0.00329	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—EGFR—bile duct cancer	0.00309	0.00326	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—MMP2—bile duct cancer	0.00309	0.00326	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—MMP2—bile duct cancer	0.00309	0.00326	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—NRAS—bile duct cancer	0.00303	0.00319	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—MMP2—bile duct cancer	0.00298	0.00314	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—MMP2—bile duct cancer	0.00298	0.00314	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—MMP2—bile duct cancer	0.00296	0.00313	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—ERBB2—bile duct cancer	0.00294	0.00311	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—KRAS—bile duct cancer	0.00292	0.00308	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—MET—bile duct cancer	0.00287	0.00303	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—ERBB2—bile duct cancer	0.00284	0.003	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—ERBB2—bile duct cancer	0.00282	0.00297	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—NRAS—bile duct cancer	0.00277	0.00292	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—EGFR—bile duct cancer	0.00276	0.00291	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—MET—bile duct cancer	0.00275	0.0029	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—MMP9—bile duct cancer	0.00273	0.00288	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—ERBB2—bile duct cancer	0.0027	0.00285	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—ERBB2—bile duct cancer	0.0027	0.00285	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—MET—bile duct cancer	0.00264	0.00279	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—MET—bile duct cancer	0.00264	0.00279	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—ERBB2—bile duct cancer	0.00261	0.00275	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—ERBB2—bile duct cancer	0.00261	0.00275	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00261	0.00275	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—KRAS—bile duct cancer	0.00261	0.00275	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—ERBB2—bile duct cancer	0.0026	0.00274	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—MET—bile duct cancer	0.00255	0.00269	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—MET—bile duct cancer	0.00255	0.00269	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—MMP9—bile duct cancer	0.00252	0.00266	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—EGFR—bile duct cancer	0.00252	0.00266	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—MET—bile duct cancer	0.00251	0.00265	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—HRAS—bile duct cancer	0.00248	0.00262	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—MMP9—bile duct cancer	0.00244	0.00257	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—NRAS—bile duct cancer	0.00242	0.00256	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—MMP9—bile duct cancer	0.00241	0.00255	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—MMP2—bile duct cancer	0.0024	0.00253	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—KRAS—bile duct cancer	0.00238	0.00251	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—IL6—bile duct cancer	0.00238	0.00251	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—SMAD4—bile duct cancer	0.00234	0.00247	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—MMP9—bile duct cancer	0.00232	0.00245	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—MMP9—bile duct cancer	0.00232	0.00245	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—MMP2—bile duct cancer	0.00229	0.00242	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bile duct cancer	0.00225	0.00238	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—TGFB1—bile duct cancer	0.00225	0.00238	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—NRAS—bile duct cancer	0.00224	0.00236	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—MMP9—bile duct cancer	0.00224	0.00236	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—MMP9—bile duct cancer	0.00224	0.00236	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—MMP9—bile duct cancer	0.00223	0.00235	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—HRAS—bile duct cancer	0.00221	0.00234	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—EGFR—bile duct cancer	0.00221	0.00233	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—MMP2—bile duct cancer	0.0022	0.00232	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—MMP2—bile duct cancer	0.0022	0.00232	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—NRAS—bile duct cancer	0.00216	0.00228	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—NRAS—bile duct cancer	0.00214	0.00226	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—MMP2—bile duct cancer	0.00212	0.00224	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—MMP2—bile duct cancer	0.00212	0.00224	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—IL6—bile duct cancer	0.00212	0.00224	CbGpPWpGaD
Tocainide—CYP1A2—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.00211	0.00223	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—ERBB2—bile duct cancer	0.0021	0.00222	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—MMP2—bile duct cancer	0.00209	0.00221	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—KRAS—bile duct cancer	0.00209	0.0022	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—NRAS—bile duct cancer	0.00206	0.00217	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—NRAS—bile duct cancer	0.00206	0.00217	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—EGFR—bile duct cancer	0.00204	0.00215	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—HRAS—bile duct cancer	0.00203	0.00214	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—ERBB2—bile duct cancer	0.00201	0.00212	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—TGFB1—bile duct cancer	0.00201	0.00212	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—NRAS—bile duct cancer	0.00198	0.00209	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—NRAS—bile duct cancer	0.00198	0.00209	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—NRAS—bile duct cancer	0.00198	0.00208	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—EGFR—bile duct cancer	0.00197	0.00208	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—EGFR—bile duct cancer	0.00195	0.00206	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—IL6—bile duct cancer	0.00194	0.00205	CbGpPWpGaD
Tocainide—ALB—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.00193	0.00204	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—ERBB2—bile duct cancer	0.00193	0.00204	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—ERBB2—bile duct cancer	0.00193	0.00204	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—KRAS—bile duct cancer	0.00193	0.00203	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.00192	0.00202	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—EGFR—bile duct cancer	0.00187	0.00198	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—EGFR—bile duct cancer	0.00187	0.00198	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—ERBB2—bile duct cancer	0.00186	0.00196	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—ERBB2—bile duct cancer	0.00186	0.00196	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—KRAS—bile duct cancer	0.00186	0.00196	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—KRAS—bile duct cancer	0.00184	0.00194	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—TGFB1—bile duct cancer	0.00184	0.00194	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—ERBB2—bile duct cancer	0.00183	0.00193	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—EGFR—bile duct cancer	0.00181	0.00191	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—EGFR—bile duct cancer	0.00181	0.00191	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—MMP9—bile duct cancer	0.0018	0.0019	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—EGFR—bile duct cancer	0.0018	0.0019	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MET—bile duct cancer	0.00179	0.00189	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—HRAS—bile duct cancer	0.00177	0.00187	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—KRAS—bile duct cancer	0.00177	0.00187	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—KRAS—bile duct cancer	0.00177	0.00187	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00175	0.00185	CbGpPWpGaD
Tocainide—SCN5A—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.00175	0.00185	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—MMP9—bile duct cancer	0.00172	0.00182	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—KRAS—bile duct cancer	0.00171	0.0018	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—KRAS—bile duct cancer	0.00171	0.0018	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—KRAS—bile duct cancer	0.0017	0.00179	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—IL6—bile duct cancer	0.0017	0.00179	CbGpPWpGaD
Tocainide—ALB—Metabolism—FAR2—bile duct cancer	0.00166	0.00175	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—MMP9—bile duct cancer	0.00166	0.00175	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—MMP9—bile duct cancer	0.00166	0.00175	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—HRAS—bile duct cancer	0.00164	0.00173	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.00163	0.00172	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.00163	0.00172	CbGpPWpGaD
Tocainide—ALB—Vitamin B12 Metabolism—IL6—bile duct cancer	0.00162	0.00171	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.0016	0.00169	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.0016	0.00169	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—NRAS—bile duct cancer	0.0016	0.00169	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—MMP9—bile duct cancer	0.0016	0.00168	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—MMP9—bile duct cancer	0.0016	0.00168	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—HRAS—bile duct cancer	0.00158	0.00167	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—MMP9—bile duct cancer	0.00157	0.00166	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—IL6—bile duct cancer	0.00157	0.00165	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—HRAS—bile duct cancer	0.00157	0.00165	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00157	0.00165	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—NRAS—bile duct cancer	0.00153	0.00161	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—IL6—bile duct cancer	0.00151	0.0016	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.00151	0.00159	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—HRAS—bile duct cancer	0.00151	0.00159	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—HRAS—bile duct cancer	0.00151	0.00159	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—IL6—bile duct cancer	0.0015	0.00158	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—TGFB1—bile duct cancer	0.0015	0.00158	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MMP2—bile duct cancer	0.00149	0.00158	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—TGFB1—bile duct cancer	0.00148	0.00157	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—NRAS—bile duct cancer	0.00147	0.00155	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—NRAS—bile duct cancer	0.00147	0.00155	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—EGFR—bile duct cancer	0.00146	0.00154	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—HRAS—bile duct cancer	0.00145	0.00153	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—HRAS—bile duct cancer	0.00145	0.00153	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—HRAS—bile duct cancer	0.00145	0.00152	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—IL6—bile duct cancer	0.00144	0.00152	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—IL6—bile duct cancer	0.00144	0.00152	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—TP53—bile duct cancer	0.00144	0.00152	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	0.00143	0.0015	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—TGFB1—bile duct cancer	0.00142	0.0015	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—NRAS—bile duct cancer	0.00142	0.00149	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—NRAS—bile duct cancer	0.00142	0.00149	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—NRAS—bile duct cancer	0.0014	0.00147	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—EGFR—bile duct cancer	0.00139	0.00147	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—IL6—bile duct cancer	0.00139	0.00147	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—IL6—bile duct cancer	0.00139	0.00147	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—IL6—bile duct cancer	0.00138	0.00146	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—KRAS—bile duct cancer	0.00138	0.00145	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—TGFB1—bile duct cancer	0.00136	0.00144	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—TGFB1—bile duct cancer	0.00136	0.00144	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—EGFR—bile duct cancer	0.00134	0.00141	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—EGFR—bile duct cancer	0.00134	0.00141	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—TGFB1—bile duct cancer	0.00132	0.00139	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—TGFB1—bile duct cancer	0.00132	0.00139	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—IL6—bile duct cancer	0.00132	0.00139	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—KRAS—bile duct cancer	0.00132	0.00139	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—ERBB2—bile duct cancer	0.00131	0.00138	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—EGFR—bile duct cancer	0.00129	0.00136	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—EGFR—bile duct cancer	0.00129	0.00136	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.00128	0.00135	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—EGFR—bile duct cancer	0.00127	0.00134	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—KRAS—bile duct cancer	0.00126	0.00133	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—KRAS—bile duct cancer	0.00126	0.00133	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—KRAS—bile duct cancer	0.00122	0.00129	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—KRAS—bile duct cancer	0.00122	0.00129	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—KRAS—bile duct cancer	0.0012	0.00127	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—HRAS—bile duct cancer	0.00117	0.00123	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—FAR2—bile duct cancer	0.00116	0.00122	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MMP9—bile duct cancer	0.00112	0.00118	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—IL6—bile duct cancer	0.00112	0.00118	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—HRAS—bile duct cancer	0.00112	0.00118	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00109	0.00116	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—HRAS—bile duct cancer	0.00107	0.00113	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—HRAS—bile duct cancer	0.00107	0.00113	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—IL6—bile duct cancer	0.00107	0.00113	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—IL6—bile duct cancer	0.00105	0.0011	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—HRAS—bile duct cancer	0.00104	0.00109	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—HRAS—bile duct cancer	0.00104	0.00109	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—IL6—bile duct cancer	0.00103	0.00108	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—IL6—bile duct cancer	0.00103	0.00108	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—HRAS—bile duct cancer	0.00102	0.00108	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—NRAS—bile duct cancer	0.000995	0.00105	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—IL6—bile duct cancer	0.000991	0.00105	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—IL6—bile duct cancer	0.000991	0.00105	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000982	0.00104	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—IL6—bile duct cancer	0.000977	0.00103	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—TGFB1—bile duct cancer	0.000925	0.000976	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—EGFR—bile duct cancer	0.000907	0.000957	CbGpPWpGaD
Tocainide—ALB—Hemostasis—GNAS—bile duct cancer	0.000881	0.00093	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—KRAS—bile duct cancer	0.000857	0.000904	CbGpPWpGaD
Tocainide—ALB—Hemostasis—HGF—bile duct cancer	0.00084	0.000886	CbGpPWpGaD
Tocainide—ALB—Metabolism—IDH2—bile duct cancer	0.000811	0.000855	CbGpPWpGaD
Tocainide—ALB—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000763	0.000805	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—HRAS—bile duct cancer	0.000728	0.000768	CbGpPWpGaD
Tocainide—ALB—Metabolism—IDH1—bile duct cancer	0.000697	0.000735	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—IL6—bile duct cancer	0.000697	0.000735	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.000664	0.0007	CbGpPWpGaD
Tocainide—ALB—Hemostasis—NOS2—bile duct cancer	0.000644	0.000679	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—IDH2—bile duct cancer	0.000567	0.000598	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—IDH1—bile duct cancer	0.000488	0.000514	CbGpPWpGaD
Tocainide—ALB—Metabolism—SLC5A5—bile duct cancer	0.00046	0.000485	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000431	0.000455	CbGpPWpGaD
Tocainide—ALB—Hemostasis—NRAS—bile duct cancer	0.000368	0.000389	CbGpPWpGaD
Tocainide—ALB—Metabolism—GNAS—bile duct cancer	0.000357	0.000377	CbGpPWpGaD
Tocainide—ALB—Hemostasis—TGFB1—bile duct cancer	0.000342	0.000361	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—SLC5A5—bile duct cancer	0.000322	0.000339	CbGpPWpGaD
Tocainide—ALB—Hemostasis—KRAS—bile duct cancer	0.000317	0.000334	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000301	0.000318	CbGpPWpGaD
Tocainide—ALB—Hemostasis—TP53—bile duct cancer	0.000282	0.000297	CbGpPWpGaD
Tocainide—ALB—Hemostasis—HRAS—bile duct cancer	0.000269	0.000284	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—GNAS—bile duct cancer	0.00025	0.000264	CbGpPWpGaD
Tocainide—ALB—Metabolism—PTGS2—bile duct cancer	0.000192	0.000202	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PTGS2—bile duct cancer	0.000134	0.000142	CbGpPWpGaD
